Intraoperative Fluorescence Imaging Market Global Report 2026

The intraoperative fluorescence imaging market size has grown rapidly in recent years. It will grow from $0.68 billion in 2025 to $0.77 billion in 2026 at a compound annual growth rate (CAGR) of 14%. The growth in the historic period can be attributed to limited availability of real-time surgical visualization technologies, elevated rates of intraoperative complications, growing adoption of minimally invasive surgical procedures, early implementation of dye-based angiography methods, and increasing demand for precision-driven oncology surgeries.

The intraoperative fluorescence imaging market size is expected to see rapid growth in the next few years. It will grow to $1.31 billion in 2030 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to expansion of AI-powered surgical imaging systems, rising demand for precision-based and personalized surgical procedures, increasing adoption of robotic-assisted surgeries, advancements in fluorescence contrast agent technologies, and growing integration of real-time imaging in hybrid operating rooms. Key trends include AI-assisted interpretation of surgical fluorescence signals, real-time image-guided intraoperative surgical techniques, improved accuracy in tumor margin detection, integration of robotic systems with fluorescence-guided procedures, and development of next-generation near-infrared imaging contrast agents.

The growing preference for minimally invasive procedures is expected to drive the growth of the intraoperative fluorescence imaging market going forward. Minimally invasive procedures are medical techniques that utilize small incisions or natural body openings along with specialized instruments to reduce tissue damage, pain, and recovery time compared to open surgical procedures. Minimally invasive procedures are increasing primarily because they enable faster patient recovery with reduced pain and shorter hospital stays due to minimized tissue damage. Intraoperative fluorescence imaging supports minimally invasive procedures by offering real-time visualization of blood flow, tissue perfusion, and critical anatomical structures using fluorescent dyes, enabling surgeons to operate through small incisions with enhanced precision, reduced risk of injury, and improved surgical outcomes. For instance, in March 2023, according to the British Association of Aesthetic Plastic Surgeons, a UK-based surgical organization, 31,057 cosmetic surgeries were performed in 2022 in the UK, marking a significant 102% increase compared to the previous year. Therefore, the growing preference for minimally invasive procedures is driving the growth of the intraoperative fluorescence imaging market.

Leading companies operating in the intraoperative fluorescence imaging market are focusing on developing innovative solutions such as the near-infrared (NIR) fluorescence imaging module to enhance real-time tissue visualization, improve surgical precision, and support better intraoperative decision-making. A near-infrared (NIR) fluorescence imaging module is a surgical imaging technology that uses near-infrared light and fluorescent dyes to provide real-time visualization of tissues and blood flow during surgery. for example, in March 2024, Synaptive Medical Inc., a Canada-based medical device company, received FDA 510(k) clearance for Modus IR, its near-infrared fluorescence module integrated with the Modus X robotic exoscope. The solution enables surgeons to visualize indocyanine green fluorescence and blood vessels in real time during microsurgical procedures, enhancing intraoperative imaging and surgical precision.

In November 2025, FluoGuide A/S, a Denmark-based clinical-stage biotechnology company, entered into a partnership with Carl Zeiss AG to co-develop FG001 for tumor imaging and surgical margin evaluation in head and neck cancer procedures. Through this collaboration, both companies aim to integrate FG001 with ZEISS surgical imaging platforms to enhance real-time tumor visualization and improve surgical margin assessment during cancer surgeries. Carl Zeiss AG is a Germany-based technology company providing intraoperative fluorescence imaging solutions.

Major companies operating in the intraoperative fluorescence imaging market are Medtronic plc, Stryker Corporation, Intuitive Surgical Inc., Olympus Corporation, Carl Zeiss Meditec AG, KARL STORZ SE & Co. KG, Shimadzu Corporation, Hamamatsu Photonics K.K., Leica Microsystems, Richard Wolf GmbH, SCHÖLLY FIBEROPTIC GMBH, Guerbet, Diagnostic Green GmbH, LI-COR Biosciences, Activ Surgical Inc., OnLume Inc., Curadel Pharma Inc., SurgiMab SAS, FluoGuide.

North America was the dominant region in the intraoperative fluorescence imaging market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in intraoperative fluorescence imaging report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the intraoperative fluorescence imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The intraoperative fluorescence imaging market consists of revenues earned by entities by providing services such as tissue perfusion assessment, tumor margin visualization, and sentinel lymph node mapping. The market value includes the value of related goods sold by the service provider or included within the service offering. The intraoperative fluorescence imaging market also includes sales of fluorescence-guided surgery systems, intraoperative imaging cameras, real-time surgical navigation systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The intraoperative fluorescence imaging market research report is one of a series of new reports that provides intraoperative fluorescence imaging market statistics, including intraoperative fluorescence imaging industry global market size, regional shares, competitors with a intraoperative fluorescence imaging market share, detailed intraoperative fluorescence imaging market segments, market trends and opportunities, and any further data you may need to thrive in the intraoperative fluorescence imaging industry. This intraoperative fluorescence imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.